Skip to content

Effects of physical exercise and vitamin D supplementation on muscle mass of hemodialysis patients

Effects of physical training and vitamin D supplementation on muscle mass of hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8ykyws
Enrollment
Unknown
Registered
2015-06-25
Start date
2013-11-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease, hemodialysis

Interventions

Group 1: 7 patients on maintenance hemodialysis that will receive Cholecalciferol (vitamin D) suplementation, dose of 50000 UI, once a week for 4 months, capsule orally,and aerobic exercise training o
Group 2: 7 patients on maintenance hemodialysis that will receive orally a capsule of placebo once a week for 4 months, and aerobic exercise training on exercise bike (30 minutes three times a week fo
Group 3: 7 patients on maintenance hemodialysis that will receive Cholecalciferol (vitamin D) suplementation, dose of 50000 UI, once a week for 4 months, capsule orally,and will not realize aerobic ex
Group 4: 7 patients on maintenance hemodialysis that will receive orally a capsule of placebo once a week for 4 months, and will not realize aerobic exercise training.
Other
I02.233.543

Sponsors

Faculdade de Medicina de Botucatu
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals older than 18 years; with chronic kidney disease on dialysis for a period greater than or equal to three months; classified as sedentary or irregularly active according to the International Physical Activity Questionnaire (IPAQ); do not have contraindications to physical activity; and accept and sign the Informed Consent.

Exclusion criteria

Exclusion criteria: Individuals unable to understand the procedures performed; prior diagnosis of coronary artery disease; positive exercise test for cardiac ischemia; patients classified as active or very active based on the International Physical Activity Questionnaire; Patients who have suffered stroke; patients with cancer, liver failure, chronic infection or acute in activity; uncontrolled hypertension (> 160 mmHg systolic or > 100 mmHg diastolic); Use of medications that affect body composition, such as corticosteroids and antiretroviral therapy.

Design outcomes

Primary

MeasureTime frame
Significant increase in total muscle mass in the assessment before and after intervention period assessed by X-ray absorptiometry dual energy.

Secondary

MeasureTime frame
Significant increase in lower limbs muscle mass in the assessment before and after intervention period assessed by X-ray absorptiometry dual energy. ;Significant increase of overall muscle function in the assessment before and after intervention period assessed by handgrip strength.

Countries

Brazil

Contacts

Public ContactJacqueline Caramori

Faculdade de Medicina de Botucatu

jteixeir@fmb.unesp.br+5514997980427

Outcome results

None listed

Source: REBEC (via WHO ICTRP)